ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer.
Saved in:
| Title: | ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer. |
|---|---|
| Authors: | Fan Z; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China., Luo G; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China., Gong Y; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China., Liu C; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China. liuchen@fudanpci.org.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China. liuchen@fudanpci.org.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China. liuchen@fudanpci.org.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China. liuchen@fudanpci.org., Yu X; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China. yuxianjun@fudanpci.org. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2020 Oct; Vol. 27 (10), pp. 4026-4027. Date of Electronic Publication: 2020 Apr 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
